Impact of Divided Dose Schedule for Cisplatin (CDDP) on Development of Peripheral Neuropathy

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.32.60
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

Impact of Concomitant Dexamethasone Dosing Schedule on Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma

British Journal of Haematology
Hematology
2017English

Development of a Pediatric Screening Tool for Diabetic Peripheral Neuropathy

Journal of Pediatric Nursing
Pediatrics
2016English

Amelioration of Cisplatin-Induced Experimental Peripheral Neuropathy by a Small Molecule Targeting P75NTR

NeuroToxicology
ToxicologyNeuroscience
2014English

Impact of Persistent Peripheral Neuropathy on the Social Life of Colorectal Cancer Patients

Kitakanto Medical Journal
Medicine
2014English

Peripheral Glial Cells in the Development of Diabetic Neuropathy

Frontiers in Neurology
Neurology
2018English

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2015English

Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Nutraceuticals and Innovative Food Products for Healthy Living and Preventive Care
English

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy